Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel Duyvendak

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Pharmacology|December 2, 2005
Underuse of antiplatelets and inappropriate useMark Naunton, Michiel Duyvendak
Nederlands Tijdschrift Voor Geneeskunde|November 11, 2009
[Oral better than parenteral supplementation of vitamin B12]Michiel Duyvendak, Gerrit J Veldhuis
The American Journal of Medicine|November 3, 2007
Dose conversions: opportunity for errorMark Naunton, Jacobus R Brouwers, Michiel Duyvendak
European Journal of Clinical Pharmacology|January 13, 2006
Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61: 675-681)Mark Naunton, Michiel Duyvendak, Gregory M Peterson, et al.
The Annals of Pharmacotherapy|October 13, 2005
Thalidomide-associated thrombocytopeniaMichiel Duyvendak, Mark Naunton, Bert J Kingma, et al.
European Journal of Clinical Pharmacology|March 7, 2025
The effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonistsJeroen P A Houwen, Arief Lalmohamed, Jochem Zwaan, et al.
European Journal of Clinical Pharmacology|September 9, 2025
Response commentary: the effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonistsJeroen P A Houwen, Arief Lalmohamed, Jochem Zwaan, et al.
Antimicrobial Resistance and Infection Control|July 4, 2021
A mandatory indication-registration tool in hospital electronic medical records enabling systematic evaluation and benchmarking of the quality of antimicrobial use: a feasibility studyAnnemieke K van den Broek, Berend H H Beishuizen, Eric A F Haak, et al.
Atherosclerosis|September 7, 2021
Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudyMax J M Silvis, Aernoud T L Fiolet, Tjerk S J Opstal, et al.
Journal of the American Medical Informatics Association : JAMIA|October 13, 2017
Association between workarounds and medication administration errors in bar-code-assisted medication administration in hospitalsWillem van der Veen, Patricia M L A van den Bemt, Hans Wouters, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Pharmacology|December 2, 2005
Underuse of antiplatelets and inappropriate useMark Naunton, Michiel Duyvendak
Nederlands Tijdschrift Voor Geneeskunde|November 11, 2009
[Oral better than parenteral supplementation of vitamin B12]Michiel Duyvendak, Gerrit J Veldhuis
The American Journal of Medicine|November 3, 2007
Dose conversions: opportunity for errorMark Naunton, Jacobus R Brouwers, Michiel Duyvendak
European Journal of Clinical Pharmacology|January 13, 2006
Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61: 675-681)Mark Naunton, Michiel Duyvendak, Gregory M Peterson, et al.
The Annals of Pharmacotherapy|October 13, 2005
Thalidomide-associated thrombocytopeniaMichiel Duyvendak, Mark Naunton, Bert J Kingma, et al.
European Journal of Clinical Pharmacology|March 7, 2025
The effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonistsJeroen P A Houwen, Arief Lalmohamed, Jochem Zwaan, et al.
European Journal of Clinical Pharmacology|September 9, 2025
Response commentary: the effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonistsJeroen P A Houwen, Arief Lalmohamed, Jochem Zwaan, et al.
Antimicrobial Resistance and Infection Control|July 4, 2021
A mandatory indication-registration tool in hospital electronic medical records enabling systematic evaluation and benchmarking of the quality of antimicrobial use: a feasibility studyAnnemieke K van den Broek, Berend H H Beishuizen, Eric A F Haak, et al.
Atherosclerosis|September 7, 2021
Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudyMax J M Silvis, Aernoud T L Fiolet, Tjerk S J Opstal, et al.
Journal of the American Medical Informatics Association : JAMIA|October 13, 2017
Association between workarounds and medication administration errors in bar-code-assisted medication administration in hospitalsWillem van der Veen, Patricia M L A van den Bemt, Hans Wouters, et al.
Pageof 2